Loading insider details...
Latest Form 4 (Jul 15, 2026): Tender of Shares of 5,146 NUVL shares, $638.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 15, 2026 | Nuvalent, Inc. (NUVL) | Tender of Shares | 5,146 | $638.1K |
| Jun 18, 2026 | Nuvalent, Inc. (NUVL) | Grant/Award | 3,444 | n/a |
| Jun 20, 2025 | Nuvalent, Inc. (NUVL) | Grant/Award | 2,647 | n/a |
| Jun 14, 2024 | Nuvalent, Inc. (NUVL) | Grant/Award | 2,499 | n/a |
| Jun 16, 2023 | Nuvalent, Inc. (NUVL) | Grant/Award | 15,000 | n/a |
| Oct 6, 2022 | Nuvalent, Inc. (NUVL) | Grant/Award | 40,000 | n/a |
| Feb 3, 2022 | Syndax Pharmaceuticals Inc (SNDX) | Other (see footnotes) | 1,714 | $21.2K |
| Jan 3, 2022 | Syndax Pharmaceuticals Inc (SNDX) | Exercise/Conversion | 5,900 | $51.7K |
| Apr 28, 2021 | Syndax Pharmaceuticals Inc (SNDX) | Purchase | 500 | $7.7K |
| Feb 5, 2021 | Syndax Pharmaceuticals Inc (SNDX) | Other (see footnotes) | 2,665 | $21.2K |